Richard Spivey

Richard Spivey

Direktor/Vorstandsmitglied bei
USC School of Pharmacy
76 Jahre
Health Technology
Consumer Services

Profil

Richard N.
Spivey
is currently the Director at USC School of Pharmacy and a Member-Councilors Board at the University of Southern California.
He previously worked as an Independent Director at Inotek Pharmaceuticals Corp.
and Adverum Biotechnologies, Inc. He also held Principal positions at Schering-Plough Corp.
and Warner-Lambert Co. He was the Chief Scientific Officer at Meda AB and MedPointe, Inc. He was also the Head-Regulatory Affairs at Pharmacia Corp.
and G.
D.
Searle LLC.
He served as a Professor at Washington State University and held a Principal position at Boehringer Ingelheim Corp.
He earned his doctorate degrees from the University of Southern California, the University of Minnesota, and the College of Pharmacy.

Aktive Positionen von Richard Spivey

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Richard Spivey

UnternehmenPositionEnde
ALLERGAN PLC General Counsel 01.01.2015
Technik-/Wissenschafts-/F&E-Leiter 01.01.2010
MEDA AB Technik-/Wissenschafts-/F&E-Leiter 01.01.2010
Technik-/Wissenschafts-/F&E-Leiter 01.01.2002
Corporate Officer/Principal 01.01.1996
Sehen Sie sich die Erfahrung von Richard Spivey im Detail an

Ausbildung von Richard Spivey

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

85

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

  1. Börse
  2. Insiders
  3. Richard Spivey
LETZTE CHANCE | -40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT